Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Verrica Pharmaceuticals Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- −4 vs. Q3 2021
- Shares held
- 8.95M
- −216.8K (−2.4%) vs. Q3 2021
- Total value
- $82.0M
- −$32.6M (−28.5%) vs. Q3 2021
- New holders
- 5
- 18 more added
- Sold out
- 9
- 11 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 43 | $28.5M |
| Q1 2026 | 39 | $25.3M |
| Q4 2025 | 50 | $43.2M |
| Q3 2025 | 34 | $10.6M |
| Q2 2025 | 59 | $13.4M |
| Q1 2025 | 75 | $13.0M |
| Q4 2024 | 81 | $21.0M |
| Q3 2024 | 79 | $21.6M |
| Q2 2024 | 74 | $135.9M |
| Q1 2024 | 62 | $105.1M |
| Q4 2023 | 64 | $131.8M |
| Q3 2023 | 67 | $58.5M |
| Q2 2023 | 63 | $84.2M |
| Q1 2023 | 60 | $84.2M |
| Q4 2022 | 50 | $29.8M |
| Q3 2022 | 49 | $29.9M |
| Q2 2022 | 57 | $21.8M |
| Q1 2022 | 51 | $72.1M |
| Q4 2021 | 45 | $82.0M |
| Q3 2021 | 49 | $114.6M |
| Q2 2021 | 53 | $112.3M |
| Q1 2021 | 51 | $150.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Verrica Pharmaceuticals Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Carmichael Hill & Associates, Inc. | 21 | $0 | 0.00% | +21 | New |
| Group One Trading, L.P. | 100 | $1.00K | 0.00% | −300−75.0% | Reduced |
| Massmutual Trust Co FSB | 65 | $1.00K | 0.00% | +65 | New |
| STRS Ohio | 300 | $2.00K | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 200 | $2.00K | 0.00% | +200 | New |
| Ameritas Investment Partners, Inc. | 1,080 | $10.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,437 | $13.0K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 3,100 | $25.0K | 0.00% | −1,400−31.1% | Reduced |
| Spire Wealth Management | 3,828 | $35.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 4,296 | $39.0K | 0.00% | +2,663+163.1% | Added |
| UBS Group AG | 4,363 | $40.0K | 0.00% | +517+13.4% | Added |
| BNP Paribas Arbitrage, SA | 4,489 | $41.1K | 0.00% | +1,910+74.1% | Added |
| Royal Bank of Canada | 5,389 | $49.0K | 0.00% | +2,672+98.3% | Added |
| Allspring Global Investments Holdings, LLC | 5,703 | $52.0K | 0.00% | +5,703 | New |
| California State Teachers Retirement System | 6,595 | $60.0K | 0.00% | −386−5.5% | Reduced |
| American International Group, Inc. | 6,960 | $64.0K | 0.00% | −208−2.9% | Reduced |
| New York State Common Retirement Fund | 8,235 | $75.0K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 8,161 | $75.0K | 0.00% | +420+5.4% | Added |
| Beck Mack & Oliver LLC | 10,000 | $92.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 10,392 | $96.0K | 0.00% | −10,341−49.9% | Reduced |
| PDT Partners, LLC | 10,800 | $99.0K | 0.01% | +10,800 | New |
| Rhumbline Advisers | 13,348 | $122.0K | 0.00% | +372+2.9% | Added |
| Tower Research Capital LLC (TRC) | 15,769 | $144.0K | 0.00% | +14,996+1,940.0% | Added |
| Barclays PLC | 15,896 | $146.0K | 0.00% | +10,544+197.0% | Added |
| Alliancebernstein L.P. | 19,100 | $175.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 22,529 | $206.0K | 0.00% | +1,068+5.0% | Added |
| JPMorgan Chase & Co | 24,585 | $225.0K | 0.00% | −5,927−19.4% | Reduced |
| Bank of America Corp | 28,451 | $260.0K | 0.00% | +18,393+182.9% | Added |
| Nuveen Asset Management, LLC | 32,788 | $297.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 33,450 | $307.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 45,932 | $420.0K | 0.00% | +730+1.6% | Added |
| MML Investors Services, LLC | 50,875 | $466.0K | 0.00% | +6,000+13.4% | Added |
| Millennium Management LLC | 94,220 | $863.0K | 0.00% | +77,590+466.6% | Added |
| Altium Capital Management LP | 97,887 | $897.0K | 0.25% | −158,357−61.8% | Reduced |
| Steel Peak Wealth Management LLC | 133,211 | $1.22M | 0.07% | +500.0% | Added |
| Northern Trust Corp | 139,837 | $1.28M | 0.00% | −616−0.4% | Reduced |
| Geode Capital Management, LLC | 217,828 | $2.00M | 0.00% | −20,241−8.5% | Reduced |
| State Street Corp | 226,416 | $2.07M | 0.00% | −1,230−0.5% | Reduced |
| Fosun International Ltd | 282,408 | $2.59M | 0.15% | 00.0% | Unchanged |
| FMR LLC | 645,496 | $5.91M | 0.00% | +408,547+172.4% | Added |
| Vanguard Group Inc | 692,195 | $6.34M | 0.00% | +190.0% | Added |
| Kornitzer Capital Management Inc | 708,976 | $6.49M | 0.10% | −19,260−2.6% | Reduced |
| BlackRock Inc. | 794,466 | $7.28M | 0.00% | +149,248+23.1% | Added |
| Morgan Stanley | 910,988 | $8.35M | 0.00% | +866,408+1,943.5% | Added |
| Perceptive Advisors LLC | 3,610,412 | $33.1M | 0.51% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −1,479,733−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −56,278−100.0% | Sold out |
| Capital Investment Advisory Services, LLC | 0 | $0 | 0.00% | −15,125−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −12,465−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −10,944−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −897−100.0% | Sold out |
| Benjamin F. Edwards & Company, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −300−100.0% | Sold out |